The previous studies from this laboratory of meningococcus infection, particularly those on the carrier problem (1), had left certain important questions unanswered which from their nature could best be investigated during a localized epidemic. Among such questions was the duration of the carrier state when this was due to known "epidemic" or disease-producing strains as contrasted with the presumably saprophytic or avirulent strains met with in the case of groups of healthy persons studied and reported in the earlier paper (1) . Further, the whole question of the exact nature of the carrier state in the case of the menlngococcus was doubtful. Was it to be looked upon as a true infection of the body by the organisms, albeit more or less localized to the nasopharyngeal mucous membrane, or was the relationship between meningococcus and host of much less intimate nature involving no reaction of the host to the organism? It was certainly desirable to obtain closer information as to the virulence of strains, epidemic or sporadic, from the spinal fluid or the nasopharynx, than had hitherto been available. The latter investigation depended, of course, on the introduction and perfection of a suitable test for meningococcus virulence in experimental animals.
With the unanswered questions in mind an invitation from Colonel Addison Davis of the 6th Corps Area Headquarters, Chicago, to participate in the investigation of an outbreak of cerebrospinal meningitis in a Civilian Conservation Corps lumber camp in Wisconsin was gratefully accepted. 1 1 My thanks are due to all those with whom I worked whose efforts made such detailed work possible, especially to Colonel Addison Davis, to Major A. P. Hitchens, to Lieutenant B. L. Camp, to Lieutenant T. Ennis, to Dr. W. D. StovaU, 545
Investigation commenced on Feb. 22, 1934, at C.C.C. Camp Rusk, Wisconsin, a camp with a personnel of 215, situated 25 miles from the nearest town. The population of the latter was approximately 3,500. The history of the epidemic up to that time was as follows: On Nov. 25, 1933, a case of cerebrospinal meningitis occurred in a C.C.C. worker. Since that time 5 other cases had occurred in the camp and 8 in the civilian population of about 6,000 persons. In point of time the cases had been well scattered, occurring every 1 or 2 weeks between Nov. 25 and the date that the investigation was commenced. The camp had been intermittently in quarantine, but before this was first applied and at intervals thereafter contact between the camp and the civilian population had been very close. No strains of meningococci had been recovered by the military authorities working with a mobile laboratory, but Dr. Stovall of the Wisconsin State Board of Health had isolated 2 strains and identified them as "Type I I I " meningococci. During the 32 days spent at the camp by the present author only 2 fresh cases occurred. Any problems, therefore, which were connected with cases of the frank disease itself could not be investigated and attention was paid to the carrier situation.
In all, 72 Type I-III and 23 Type II and 2 Type VII carriers were found in the camp. A few were found among the civilianpopulationbut, unfortunately, circumstances did not allow a detailed examination for carriers outside the camp. The work in the camp was necessarily confined, for the most part, to the study of the carriers, the approximate degree of their infection and the length of duration of the carrier state. This was supervised personally for a little over 4 weeks and was then carried on for another 6 weeks first by Major A. P. Hitchens and later by Dr. Ernest Q. King, both of whom have kindly given permission for the inclusion of their records in this paper.
In addition to the work carried on at the camp itself, cultures of carrier strains and samples of blood from the carriers were obtained and were brought back to the laboratories at The Rockefeller Institute where further investigations were made. It is realized that the results with the carrier and case strains, especially with regard to the virulence tests, are somewhat unsatisfactory on account of the interval elapsing between the isolation of the strain and the carrying out of the virulence test. The arrangements made, however, were the best possible under the circumstances. As far as throwing light on the duration of the cartier state is concerned, the results are unsatisfactory. Owing to the need for closing the camp as soon as possible, the authorities transferred the men or sent them home very early--in some cases even when the last swab had been positive for meningococci. Many other carriers were still positive, or had been so recently, when the investigation closed. As has been shown elsewhere (1) , carriers may still be found positive even after 4] months of negative swabbings. This being so, it could not, of course, be said that any of these carriers cleared up, the total duration of the investigation being only 2½ months. It seems probable that the clearing up of the carrier state should be based on negative weekly swabs lasting over a period of at least 2 or 3 months, since 3 consecutive negative weekly swabbings are of little value when assessing the normal duration of the carrier condition (1). Even if, however, the basis of 3 consecutive weekly swabbings should be adopted as indicating a cure, the results obtained in the present investigation were unsatisfactory. Thus:--I ~ carriers were still positive when swabbing ceased. II J I 1 carriers showed only 1 negative culture when swabbing ceased. II J I / carriers showed only 2 negative cultures when swabbing ceased.
RESULTS
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I ~ carriers showed only 3 negative cultures when swabbing ceased and III the period from the last positive to the last negative was less than 3 weeks.
It is clear, therefore, that 42 out of 72 Type I carriers and 20 out of 23 Type II carriers, on any of the criteria accepted for the "cure" of meningococcus carriers, were still potentially affected when the investigation ended.
It is with these considerations in mind that the table showing the duration of the carrier state during epidemic conditions at Camp Rusk should be examined (Table I ). It will then be seen that, on the basis of "cure" constituted by 3 consecutive weekly negative swabs, 37.5 per cent of Type I carriers lasted 4 weeks or less, 33.5 per cent lasted 5 weeks or over and 29.3 per cent were still potentially affected when last seen, having lasted 4 weeks or less up to that time. With the Type I I carriers 13 per cent lasted 4 weeks or less, 4.3 per cent (this represents only 1 case) 5 weeks or more and 82.7 per cent were still potentially affected when last seen. + + = negative swabbings not obtained 3 times at weekly intervals in these carriers. Even on this basis, then, the number of Type I carriers remaining positive for over 5 weeks was high. The figure was comparable to that recorded by Flack (2) . He showed that 47.59 per cent of contact carriers lasted over 4 weeks and 52.41 per cent under 4 weeks. In non-contacts the average duration was shorter and the figures were 27.77 per cent and 72.23 per cent respectively. The experience in this laboratory has been contrary to that of Flack in that non-contacts, carrying atypical strains, tend to be chronic carriers (1).
It is believed that the average duration of the carrier state as demonstrated at Camp Rusk or as recorded anywhere in the literature is put somewhat, and probably much, too low. In the case of the Camp Rusk epidemic another variable factor occurred in the change of personnel which took place twice during the investigation. Although exactly the same equipment be available and the same technique be adopted in each case, there is no doubt that the personal element is very great in any method used for the detection of meningococcus carriers. The individual who has had several years of close experience with this work will inevitably find a higher percentage of positive throat plates than anyone coming to the task relatively inexperienced.
It is undoubtedly true that the greater number of these carriers at Camp Rusk, carrying typical Type I or Type II (epidemic) strains, did not give such constantly positive plates as had been usual amongst the non-contact group carrying, for the most part, strains not identical with Gordon's 4 types; that is, what might be called non-epidemic strains (1). This fact, added to the fact that the demonstrable carrier duration with epidemic strains was relatively short, might be taken in support of the theory that virulent strains of meningococci are carried for only short periods as compared with the comparatively nonvirulent or even saprophytic strains. This would be in accord with the known facts with regard to pneumococcus carriers (3) (4) (5) . On the other hand, it must be borne in mind that laboratory conditions at the C.C.C. camp were by no means ideal and that this fact together with the changing personnel would undoubtedly affect the work adversely and produce a higher percentage of apparently negative throat cultures than was actually the case. The question of duration of the carrier state when virulent (epidemic) typical meningococcus strains are concerned, which is an important unsolved problem, must still be regarded as sub judice.
Virulence of Strains for Mice
A study of the virulence of meningococcus strains gathered during an epidemic depended, of course, entirely on the existence of a suitable animal test. Such a test had not been available, at least in small laboratory animals, until Miller (6) described his method of producing experimental meningococcal infections in mice by the use of mucin suspensions. A study of this method confirmed all t h a t Miller had claimed for it and showed that, at least in certain susceptible breeds of mice, it gave consistent results which could be used as a basis for the titration of meningococcal virulence. 2 The following has been adopted as the standard method for the titration of the virulence of meningococcus strains. A 6 per cent solution of hog's gastric mucin at pH 7.4 is prepared according to the method described by Miller. The strain to be investigated is grown for 16 to 18 hours on a 10 per cent rabbit's blood pneumococcus agar. It is then washed off in normal saline and the saline suspension diluted until a standard suspension, containing 2,000,000,000 organisms to the cubic centimeter, is obtained. Dilutions of this suspension, each 1 in 10, are made in the 6 per cent mucin. For most strains it has been found that dilutions from 10 -s to 10 -e are sufficient for the titration of virulence. A cubic centimeter of 10 -~ dilution will contain 20,000,000 organisms and a cubic centimeter of 10 -e, 2,000 organisms. 1 cc. of the 6 per cent mucin suspension of each dilution is injected intra-abdominally into at least 2 mice. It is important that all steps involving the meningococci, from the time they are washed from the plate until the inoculation is made, be carried out as rapidly as possible. The lowest dilution at which all mice die is taken as the end-point, but any deaths beyond this point are indicated by a + sign. Thus, if all mice die at 10 -5 and only I out of 2 or 3 at 10 -5, the virulence is given as 10-5+. It has been found that in order to obtain consistent results the susceptible breed of white-face mice is the most satisfactory of those yet tested.
Using this method of virulence titration, 34 strains isolated from the carriers at Camp Rusk were tested after they were brought back to the laboratory at the Institute. Of these strains, 14 were T y p e I, 12 T y p e II, 3'Type V I I and 5 were Neisseria catarrhalis strains isolated from carriers. Table I I shows the mouse virulence of these strains.
I t is clear from Table I I t h a t the majority of T y p e I strains had a high virulence, 78.6 per cent showing a virulence of 10 -5 or greater. There is no explanation why one T y p e I strain should have failed to kill at all. At the time it was titrated it had been isolated from the nasopharynx 24 days, and the average elapsed time for T y p e I strains was 24. the Type II strains is significantly less than that of the Type I. 66.7 per cent of Type II strains have a virulence of 10 -~ + and only 1 strain (out of 12) has a virulence greater than this. The virulence of the atypical Type VII strains was much less, the most virulent strain being only 10 -2 + , while the strains of N. catarrhalis were completely avirulent with the exception of one that killed at 10 -3.
The high virulence of Type I strains and the moderately high but lesser virulence of Type II strains are interesting. It seems probable that the epidemic was produced by Type I or Group I-III strains. In favor of this are the following facts. Both cases occurring during the personal investigation of the epidemic were Type I cases and one of them occurred in a known Type I carrier; Dr. StovaU had isolated 2 Type III strains at an earlier date; one of the cases proved later to be a Type I carrier, being found positive once 5 months after the onset of the meningitis (this is of doubtful significance; it may have been only a new infection from contact with other carriers); the Type I carrier rate was 33.5 per cent which is well over the "explosion point" of 20 per cent. On the other hand, it is possible that some cases may have been due to Type II organisms. One case, that was seen very shortly after the meningitis had disappeared, never showed any Type mmINOOCOCCUS INFECTION. VII I organisms in the nasopharynx but showed a Type II strain once 40 days after the onset of the disease; a specimen of spinal fluid taken from a civilian case at the height of the illness proved later to have precipitinogens which reacted moderately with Type II antimeningococcus serum (unfortunately no strain had been isolated from this patient at the time she was sick but her blood, taken 3 weeks after the onset of the disease , showed Type II agglutinins and protective antibodies as described below); finally, the Type II carrier rate of 10.7 per cent, while not very high, is a high normal figure and might be compatible with the appearance of a few Type II cases. The relative virulence of the 2 types as isolated from carriers might also be taken as suggestive of a main Type I epidemic with some Type II c a s e s .
The Nature of the Carrier State
The nature of the carrier state in meningococcus infections has stirred up much controversy. The fundamental question at issue is whether this can be looked upon as a true infection or not. Are we to believe that the meningococcus on being implanted on the mucous surface of the nasopharynx causes any reaction within the host either local in the way of inflammation or general in the way of serological and other changes, or are we to look on the meningococcus carrier state as a more or less passive symbiotic relationship much like that of the Staphylococcus albus on the skin or DSderlein's bacillus in the vagina? Although some investigators (7) have claimed that meningococci usually, if not invariably, cause an inflammation of the mucosa of the nasopharynx, and although reports of epidemics of meningococcal nasopharyngitis preceding or running concurrently with epidemics of meningitis exist, nevertheless these are usually discounted and apparently the feeling of the majority of workers, whether pubfished or not, is that the meningococcus produces no reaction in the mucosa and that the carrier state in this disease is not to be looked upon as an infection.
In the case of other organisms carried, as is the meningococcus, in the nasopharynx, there is the same lack of unanimity of opinion as to the precise status of the carrier condition. With the pneumococcus, however, there is some evidence from two different angles that the carrier state is in the nature of an infection. Thus, Webster and Hughes (5) concluded that the numbers and degree of infection of pneumococcus carriers varied directly with the incidence of coryza, sore throat and other respiratory tract diseases. They thought that pneumococcus carriers are infected individuals with organisms growing in their nasopharyngeal tissues, and further that the presence or absence of the carrier state depended on the resistance of the host, a factor which varied with the season of year. Bull and McKee (8) had shown that a certain number of rabbits which gave no sign of infection following intranasal instillation of pneumococci developed protective antibodies and that their serum contained agglutinins and fixed complement. Neufeld and Tulczynska (9) also were able to show that mice inoculated intranasally with pneumococci and becoming carriers acquired an immunity which was higher the longer the carrier state persisted. They thought that the immunity might be due to passage of a few organisms through the nasal mucosa, the absorptive capabilities of which were considered to be very good. The latter assumptions have been shown elsewhere to be true (10) .
Studies of pneumococcus carriers (5) and meningococcus carriers (1) in an unselected group of individuals who had had no known contact with the frank disease have shown a striking similarity to exist between the two conditions. It was therefore obviously necessary to examine the meningococcus carrier state carefully to determine whether this is to be regarded as an infection or not.
A study of coryza, pharyngitis and upper respiratory disease in a group of non-contact carriers (1) and in the carriers at Camp Rusk has failed to reveal any direct relationship between these inflammatory conditions and the duration or extent of the carrier state. Indeed, the only possible relationship, and this was little more than suggested, was that any infection accompanied by the copious outgrowth of a pathogen, such as Hemophilus influenzae or pneumococcus, caused the numbers of meningococci to decrease.
Attention was therefore paid to the reactions of the serum in known meningococcus carriers. Serum was obtained from 41 carriers of which 31 were Type I and 10 Type II. Serum was also obtained from 9 recovered cases, 8 of which had had intensive serum therapy both intravenous and intrathecal. In every case the serum was tested for the presence of agglutinins and in the case of 12 Type I and 5 Type II sera and also sera from 4 recovered cases, tests were made for the presence of protective antibodies.
The agglutination tests were set up in a 37°C. water bath and then allowed to stand overnight in the ice box. The serum was tested against freshly isolated and readily agglutinable Type I and Type II strains at final serum dilutions of 1/10, 1/20 and 1/40. Of the 31 Type I sera, 21 gave no agglutination or one that was slight and equal with both Type I and Type 1I organisms, 6 gave moderate agglutina, tion to 1/20 without any cross-agglutination or even slightly to 1/40 and 4 gave good agglutination out to 1/40. Of the 10 Type II sera, 4 gave no agglutination or one that was slight and equal with both Type I and Type II organisms, 4 gave a moderate agglutination and 2 gave good agglutination (Table III) . 21 sera from normal indlviduals or from persons suffering from epidemic encephalitis failed to agglutinate either Type I or Type II organisms under the conditions of the experiment. In the protection tests use was made of the virulence test with mucin suspensions as outlined above. 0.2 cc. of the serum to be tested was injected intraperitoneally into white-face mice 30 minutes to 1 hour before inoculation of the mucin suspension of organisms. The test serum was titrated against suspensions of the organisms ranging from 10 -2 to 10 -~ of the standard suspension (2,000,000,000 per cc.) using 2 mice at each dilution. Control tests were made at the same time that a batch of sera from carriers was tested and consisted of a test without any serum, one with presumably normal pooled human serum s and a third with Type I or Type II antimeningococcal horse serum of known protective potency.
Since 2 cc. of serum was the minimum required for each protection test even when tested only against organisms homologous with the type carried in the throat of the individual from whom the serum was obtained, only a limited number of the sera collected could be te~ted. In all, 3 experiments were made and 12 sera from Type I carriers and 5 from Type II carriers were tested. The results are shown in Table IV .
From an examination of Table IV it will be seen that 3 Type I carrier sera and 2 Type II give good protection, 5 Type I sera give a certain amount of protection as compared with the controls and 4 Type I and 3 Type II sera give no protection. In Table III these sera are shown ranged according to whether their protection was good, moderate or high, and compared with the agglutination of the same and other carrier sera also arranged in 3 somewhat arbitrary groups. It is obvious that the correspondence between content of agglutinins and content of protective antibodies as demonstrated by these tests is not close. Of the 17 sera with which both agglutination and protection tests were done, 11 showed some correspondence in containing both agglutinins and protective antibodies, while 6 showed no correspondence.
Nine sera from recovered cases were obtained. Of these only one (No. X) had not received treatment with antimeningococcal polyvalent serum. This serum gave a moderate agglutination against Type II meningococci and good protection against Type II organisms. No strain had ever been isolated from this case but the spinal fluid drawn at the height of the disease gave a moderately strong precipitin 3 Owing to the limited number of white-face mice available, it was not possible to perform protection tests with large numbers of normal human sera. Under these circumstances it was decided to pool 4 normal sera and use this as a control in each protection test. Since 4 different sera were used with each test, 12 control sera in all were tested. reaction with Type II monovalent serum. In the 8 cases in which serum therapy had been administered 1 to 4 months before blood was drawn for testing, 6 (Nos. 30, 81 b, 106, 154, Y, Z) showed no agglu- It seems clear from these results on the carrier sera that there is, in a certain percentage of cases, some general reaction of the body, at least serological, to the presence of meningococci in the nasopharynx. Thus, 32.3 per cent of Type I carrier sera tested and 60 per cent of Type II sera tested showed moderate or good agglutinins for homologous organisms. Also 80 per cent of Type I sera tested'and 40 per cent of Type II sera tested showed moderate or good protective antibodies against homologous organisms.
Despite the absence of any convincing local infection in meningococcus carriers, this general reaction of the body would seem to point to the fact that the carrier state is to be looked upon as an infection. It seems probable that small numbers of meningococci are continually making their way through the mucosa and that these organisms, entering the local tissues and also the blood and lymph streams, are sufficient to produce immune reactions. Such is known to be the case with experimental pneumococcus infections in animals (8, 10) .
It was unfortunately quite impossible to obtain any idea in these individuals as to how long the carrier state had existed. It can only be said that for the great majority it probably was not over 9 months, the length of time the camp had been in existence, and that for many it was probably not more than 4½ months, which was the time since the first case appeared in the camp and the time at which date the carrier rate probably first greatly exceeded 20 per cent.
S~A R Y AND CONCLUSIONS
The investigation of this isolated epidemic of meningococcus meningitis at a C.C.C. camp gave an opportunity to examine the carrier state in contacts carrying what were presumably virulent epidemic strains of organisms.
With the aid of Miller's technique for the enhancement of the demonstrable virulence of meningococci for mice, it proved possible to test the virulence of the carrier strains from Camp Rusk. These
